Home › Therapeutic areas › Ophthalmology › Autosomal Recessive Bestrophinopathy
Autosomal Recessive Bestrophinopathy (1 companies)
Companies with an active program in Autosomal Recessive Bestrophinopathy.
| Ticker | Company | Therapeutic areas | Programs | Lead stage | Mkt cap | Programs |
|---|---|---|---|---|---|---|
| IRD | Opus Genetics | Ophthalmology Rare | 1 | Approved | $348M | 12 |
No companies match.